A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of
KHK6640, given as a single dose in Japanese patients with Mild to Moderate Alzheimer's
Disease.